CAPITAL HEALTH SYSTEM, INC. v. VEZNEDAROGLU

CourtDistrict Court, D. New Jersey
DecidedApril 30, 2021
Docket3:15-cv-08288
StatusUnknown

This text of CAPITAL HEALTH SYSTEM, INC. v. VEZNEDAROGLU (CAPITAL HEALTH SYSTEM, INC. v. VEZNEDAROGLU) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CAPITAL HEALTH SYSTEM, INC. v. VEZNEDAROGLU, (D.N.J. 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY CHAMBERS OF CLARKSON §&. FISHER FEDERAL MICHAEL A. SHIPP BUILDING & U.S. COURTHOUSE UNITED STATES DISTRICT JUDGE 402 EAST STATE STREET TRENTON, N.J. 08608 609-989-2009 NOT FOR PUBLICATION April 29, 2021 LETTER OPINION & ORDER VIA CM/ECF All counsel of record Re: Capital Health Systems, Inc. v. Veznedaroglu et al. Civil Action No. 15-8288 (MAS} (LHG) Dear Counsel: This matter comes before the Court upon Plaintiff! Alireza Maghazehe’s Appeal of Magistrate Judge Goodman’s September 9, 2020 Letter Order. (ECF No. 351.) Defendants Global Neurosciences Institute, LLC (“GNI”), Drs. Erol Veznedaroglu, Kenneth Liebman, Mandy Binning, and Zakaria Hakma. (collectively, “Defendants”) opposed (ECF No. 359), and Plaintiff replied (ECF No. 362). The Court has carefully considered the parties’ submissions and decides the matter without oral argument pursuant to Local Civil Rule 78.1. For the reasons set forth below, the Court affirms Judge Goodman’s September 9, 2020 Letter Order. (ECF No. 344.) I. Background This matter’s underlying facts and procedural history are known to the parties, and therefore the Court only recites those facts necessary to resolve the instant dispute. Plaintiff is President and CEO of Capital Health‘Systems, Inc. (“Capital Health”). Dr. Maghazehe and Capital Health (collectively “Plaintiffs”) allege, inter alia, that Defendants used improper means to access confidential information from Capital Health, violated a non-solicitation provision, and stole Capital Health’s Transfer Hotline. (Second Am. Compl. at [J 86-92, ECF No. 101.) Defendants subsequently filed a Complaint and Demand for Jury Trial under a separate docket (RICO Compl., Glob. Neurosciences Inst. v. Cap. Health Sys., No. 3:16-cv-1972 (D.N.J. Apr. 13, 2016), ECF No. 1), which was consolidated into this action on April 13, 2016. (Consol. ' This appeal was filed on behalf of Dr. Maghazehe. However, Maghazehe and his employer, Capital Health Systems, Inc., filed the underlying complaint as co-plaintiffs. In the cross-complaint that was consolidated with this matter Maghazehe and CHS are designated as “Consolidated Defendants.” For ease of reference, Maghazehe and CHS will be referred to here collectively as “Plaintiffs” and Global Neurosciences Institute. LLC et al. as “Defendants.”

Order, ECF No. 85.) On May 23, 2016, Defendants filed a consolidated RICO Case Statement, as ordered by Judge Goodman, wherein they alleged that Plaintiffs engaged in a broad and systematic scheme to misappropriate the GNI] neurosurgery practice (RICO Case Statement at 32, ECF No. 97). The RICO Case Statement also includes a copy of a complaint filed against Capital Health by Dr. Nigahus Karabulut (“Dr. Karabulut”) on May 17, 2016 in the Superior Court of New Jersey. at 14, 24, 30; Ex. B). Discovery in this matter took place over the course of 2017 and 2018, with extended fact discovery ultimately set to conclude by November 30, 2018. The schedule was amended several times as the parties engaged in discovery (ECF Nos. 144, 148, 155, 180, 188, 197. 204, 232), and filed numerous discovery-related and other motions. See, e.g., ECF Nos. 151, 166, 167, 168, 209 (motions to compel discovery from a third party); ECF No. 162 (motion to disqualify counsel); ECF No. 66 (motion for reconsideration); ECF Nos. 82, 213 (motions to amend). On November 26, 2019, Judge Goodman denied Capital Health’s Motion to File a Third Amended Complaint (Mot. to Am., ECF No. 213), which sought relief based on allegedly concealed evidence that Capital Health said it was only able to discover through third-party subpoenas. (See Order Den. Mot. to File Third Am. Compl. at 6, ECF No. 247.) In its ruling, the Court rejected Capital Health’s argument that it had good cause to amend at that late stage because Defendants had allegedly concealed evidence of their fraudulent behavior in discovery. (/d. at 14.) The timeline of the case contradicted Capital Health’s diligence argument: it showed that Capital Health had obtained the critical information by April 25, 2018, i.e.. more than a year prior to filing its Motion to Amend. (/d, at 12-15.) Further, the Court entered two amended pretrial scheduling orders (ECF Nos. 180, 188), both prepared by Capital Health, after Capital Health received the subpoenaed documents with the information that formed the basis for its proposed amendments. (/d. at 13.) Yet, at no point did Capital Health ask the Court to extend the deadline to file a motion to amend the pleadings. (/d. at 14} Consequently, the Court denied the Motion to Amend because Capital Health failed to act with appropriate diligence. (/d. at 16-17.) The Motion to Strike On March 9, 2020, Plaintiffs again alleged discovery violations by Defendants. this time in a Motion to Strike and for Sanctions (Mot. to Strike, ECF No. 301.) In particular, Plaintiffs alleged that: (1) Defendants intentionally concealed damaging communications that were ultimately obtained via third-party subpoena from ECG Consultants, a management consulting firm hired by GNI (Pls.” Br. in Supp. of Mot. to Strike at 4-7, ECF No. 302); (2) Defendants submitted false answers to interrogatories and failed to supplement their Rule 26 disclosures. Although Defendants indicated they had fully disclosed available information regarding the witnesses referred to in paragraphs 90 and 129 of

their initial RICO Complaint, (id. at 11), Plaintiffs allege that Defendants knew and withheld the names of these witnesses for nearly two years. (/d. at 11-12) Despite not supplementing their disclosures with the names of these witnesses, Defendants relied on their statements in various filings, including their Opposition to Plaintiffs’ Motion for Summary Judgment (Defs.” Opp’n to Mot. Summ. J., ECF No. 291) (Mem. Supp. Mot. Strike, at 17); (3) Defendants failed to identify Dr. Karabulut as an individual likely to have discoverable information in their Initial Disclosures. (/d. at 17) Yet they relied on a declaration by Dr. Karabulut (the “Karabulut Declaration,” see Ex. 37 to Coccia Decl., ECF No. 291) in their opposition to Capital Health's Motion for Summary Judgment. (/d. at 17). Further, Plaintiffs alleged that the Karabulut Declaration directly contradicts testimony that was provided by Defendants in Dr. Karabulut’s New Jersey Superior Court litigation against Capital Health. (/d. at 17-18). Based on these claims, Plaintiffs asked the Court to strike from Defendants* opposition to Plaintiffs’ motion for summary judgment the Karabulut Declaration and all information and witnesses not disclosed by Defendants pursuant to Federal Rule of Civil Procedure 26,” as well as to impose financial sanctions on Defendants for their discovery abuses pursuant to Rule 37(c). (/d. at 24-25.) Judge Goodman’s Ruling . In her September 9, 2020 Letter Order denying the motion (Letter Order at 8, ECF No, 344), Magistrate Judge Goodman examined each of these allegations in turn. With respect to the first claim, Plaintiffs did not specifically ask for any remedy or sanctions. Rather, as clarified in their Appeal, they presented the allegations that Defendants withheld damaging emails to illustrate the broader pattern of Defendants’ discovery abuses. Judge Goodman noted that she had already addressed the allegations in the context of Plaintiffs’ Motion to Amend the Complaint, which Judge Goodman denied on November 26, 2019. (Order Den. Mot. to Am., ECF No. 247.) Judge Goodman found Rule 37 sanctions inapplicable to this claim, because Plaintiffs ultimately obtained the allegedly-concealed discovery within the fact discovery period through their third-party subpoena. (Letter Order at 8.) Judge Goodman noted that where a discovery abuse is “harmless,” no relief can be granted. (/d., (citing Fed. R. Civ.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. United States Gypsum Co.
333 U.S. 364 (Supreme Court, 1948)
Frank v. County of Hudson
924 F. Supp. 620 (D. New Jersey, 1996)
Cardona v. General Motors Corp.
942 F. Supp. 968 (D. New Jersey, 1996)
Gunter v. Ridgewood Energy Corp.
32 F. Supp. 2d 162 (D. New Jersey, 1998)
Marks v. Struble
347 F. Supp. 2d 136 (D. New Jersey, 2004)
Goodman v. Lukens Steel Co.
777 F.2d 113 (Third Circuit, 1985)
Cooper Hospital/University Medical Center v. Sullivan
183 F.R.D. 119 (D. New Jersey, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
CAPITAL HEALTH SYSTEM, INC. v. VEZNEDAROGLU, Counsel Stack Legal Research, https://law.counselstack.com/opinion/capital-health-system-inc-v-veznedaroglu-njd-2021.